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Abstract
OBJECTIVE: To investigate the relevance of the pi-
tuitary to liver syndromes and cancer by studying
the pituitary transcriptome profile in liver cancer
mice with different syndromes.
METHODS: The quantitative four diagnosis and
syndrome differentiation methods were used to
screen normal control mice without syndromes
(NC), liver cancer mice with poisonous pathogenic
factors syndrome (PPFS), and Qi deficiency syn-
drome mice (QDS). An Affymetrix GeneChip Mouse
Exon 1.0 ST Array was performed to detect the
gene expression of different groups. Gene cluster-
ing was applied to analyze the gene expression pat-
terns of the PPFS and QDS groups compared with
the NC group. The transcriptional networks analysis
tool, FunNet, was used to enrich the biological cate-
gories of differentially expressed genes in the PPFS
and QDS groups.
RESULTS: Biological categories of differentially ex-
pressed genes showed that excessive metabolism
and extracellular matrix interaction, insufficient
communication of cells (especially nerve cells), and
the bidirectional regulation of genetic information
processing were enriched in both syndromes. How-
ever, the degree of excessive metabolism in the
PPFS group was higher than that in the QDS group.
The hyperfunction of cancer and infection, and the
hypofunction of the nervous and endocrine sys-
tems were obvious in the QDS group.
CONCLUSION: The pituitary plays an important
role in the development of liver cancer and syn-
dromes. This study further studied the role of the
pituitary in the combination of disease and syn-
dromes.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Major advances have been made in the management of
primary hepatic carcinoma (hereafter referred to as liv-
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er cancer) in recent decades. Nevertheless, liver cancer
remains the second most common cause of death from
cancer worldwide.1 More than fifty percent of liver can-
cer patients worldwide live in China, which is a signifi-
cant public health burden. Five therapeutic methods
including resection, transplantation, radiofrequency ab-
lation, chemoembolization, and sorafenib are used to
treat liver cancer. In addition, some personalized medi-
cine approaches are used to complement the shortfalls
of these methods.2 Traditional Chinese Medicine
(TCM) is a personalized medicine system based on the
theory of syndrome differentiation and treatment,
which plays an important role in the treatment of most
diseases including liver cancer. The foundation of syn-
dromes and the mechanisms of Chinese herbs in liver
cancer treatment are still unclear, but their curative ef-
fects have been identified.3,4
Experiments indicate that both syndrome, especially
deficiency syndrome, and cancer are closely related to
the neuro-endocrine-immune network (NEIN).5,6
However, there are not many reports on the relation-
ship between NEIN and liver cancer. We have previ-
ously studied this relationship.7,8 We aimed to further
study the role of the pituitary, an important tissue of
NEIN, in the development of liver cancer and syn-
dromes. This was done by mining the pituitary tran-
scriptomic features of liver cancer mice with different
syndromes.
MATERIALS ANDMETHODS
Animals and modeling
Two hundred and fifty healthy male Kunming (KM)
mice of clean grade, weighing (25±1) g, were bought
from Shanghai SLAC laboratory animal Co., Ltd.,
(certificate of quality No. SCXK [hu] 2008-0003)
and housed at a controlled temperature (22℃±2℃）
and humidity (40%-60%), with a 12-h light-dark cy-
cle, and were allowed access to food and water ad li-
bitum. This study was approved by the experimental
animal ethics committee of Shanghai University of
TCM.
Ten mice were excluded for over- or under-weight be-
fore the experiment. Then the remaining two hundred
and forty mice were divided into two groups: normal
control group (NC, n=50) and model group (n=190).
Each mouse in the model group was injected with
0.2 mL (4×107/mL) H22 tumor cells (Shanghai Insti-
tute of Materia Medica, Shanghai, China) into the
right armpit subcutaneously to form the liver cancer
model. The same volume of normal saline was injected
into the right armpit subcutaneously of each mouse in
the NC. Forty mice in the model group were removed
one week after injection for their failure to form tu-
mors. Therefore, two hundred mice were used in the fi-
nal experiment.
Syndrome differentiation and mice with different
syndromes screening
In our preliminary study, we found that liver cancer
mice could spontaneously develop syndromes without
additional syndrome building and that the syndromes
could be identified by using the quantitative four diag-
nosis and syndrome differentiation methods estab-
lished by Fang et al. 9,10 On the 8th day after modeling,
the indexes involved in the quantitative four dig nosis
method included body weight, axillary temperature,
the number of cells across and vertically in open-field
testing within 35 seconds, grip, the r value of claws
and tails, tumor size and diameter, were measured.
According to the standard of syndrome differentiation,9,
10 the degree of poisonous pathogenic factors (PPF),
Qi, Xue, Yin, and Yang was calculated based on above
indexes. Eight liver cancer mice with lower grip and
fewer movements in open field testing, which are al-
ways used to reflect Qi deficiency, were screened and
named as the Qi-deficiency syndrome group (QDS).
Eight liver cancer mice with no significant differences
in other indexes aside from a larger solid tumor, which
is considered a poisonous pathogenic factor in TCM,
were selected and named as the poisonous pathogenic
factor syndrome group (PPFS). Finally, eight mice
with no syndromes were selected from the 50 mice in
the NC group, which was still named as the NC
group. All other mice were raised continuously for oth-
er experiments.
RNA extraction, purification, and quality control
Twenty-four mice from the NC, PPFS, and QDS
groups were sacrificed and the pituitary was removed.
Because the pituitary of each mouse was so small
(about 1.5 mg each), eight pituitaries from each group
were pooled together to extract the total RNA with
TRIzol (Gibco, Grand Island, NY, USA) and were pu-
rified with an RNeasy Mini Kit [Tiangen Biotech (Bei-
jing) Co., Ltd., Beijing, China]. Then, the integrity of
the RNA was measured with RNA 6000 Nano Lab-
Chip kit (Agilent Technologies, Santa Clara, CA,
USA) using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA). All procedures
were performed according to the protocols provided by
the manufacturers.
Microarray detections
Three cDNA microarray detections were performed
with GeneChip Mouse Exon 1.0 ST Array (Affyme-
trix, Santa Clara, CA, USA) using Affymetrix
GeneChip Operating System (Affymetrix, Santa Clara,
CA, USA) to measure the gene expression. Shanghai
Biochip Co., Ltd., (Shanghai, China) was entrusted to
finish this work and provided the relative expression of
16 654 genes for analysis.
Statistical analysis
The degree of PPF, Qi, Xue, Yin, and Yang was ana-
lyzed using statistical software SPSS 15.0 (SPSS, Chica-
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go, IL, USA) and expressed as mean± standard devia-
tion. Statistical significance was assessed using a t-test
for the degree of PPF and one-way analysis of variance
for the degree of Qi, Xue, Yin, and Yang. P<0.05 was re-
garded as a significant difference.
Differentially expressed gene screening
The expression of 16 654 genes in each chip was pro-
vided by Shanghai Biochip Co., Ltd. The differentially
expressed gene screening consisted of four consecutive
steps: first, the average expressed value of all genes in
all groups was calculated. Second, the genes whose ex-
pression in any group was greater than the calculated
average value were screened out. Third, the ratios of
PPFS to NC, and QDS to NC were computed.
Fourth, the criteria of differential expression were set
as a ratio of differentially expressed genes was greater
than 1.5 or less than 0.67.
Gene clustering representing gene expression patterns
To elucidate the gene expression patterns in both the
PPFS and QDS groups, gene clustering analysis was
performed with Gene Cluster 3.0 (Stanford University,
Stanford, CA, USA). First, all ratios of PPFS to NC
and QDS to NC were replaced by log1.5 (ratio) to ad-
just 1.5-fold up- and down-regulation (ratio was 0.67)
as the same magnitude of change, but in an opposite
direction. Some genes were up- or down-regulated if
their log1.5 ratios were greater than 1.0 or less than﹣1.0,
respectively. Second, a datafile was prepared as recom-
mended in the Cluster manual and it was loaded.
Third, the median centering of genes was created to ap-
ply a hierarchical clustering algorithm to the ratios and
genes using the Euclidean distance as the measure of
similarity and complete linkage clustering. Each ratio
in the cluster-ordered graph was identified by a graded
color (pure green through black to pure red). The visu-
al graph of the results from Cluster was performed us-
ing TreeView (Free Software Foundation, Boston,
MA, USA).
Biological categories characterizing the
transcriptomic feature of the pituitary
Based on the results from gene clustering, the gene ex-
pression patterns were different between two groups
and some genes were differentially expressed. We
aimed to classify these differentially expressed genes
based on their functions and extract the relationships
between these functions and the PPFS and QDS
groups. Therefore, we used a transcriptional network
analysis tool, FunNet (Inserm, Paris, France),11,12 which
relied on genomic annotations provided by Gene On-
tology (GO)13 and the Kyoto Encyclopedia of Genes
and Genomes (KEGG).14
To meet the requirements of the file format presented
by the online FunNet tutorial,11 the expressive value of
all differentially expressed genes in the PPFS and QDS
groups were replaced by log2 (expressive value). Data
were then searched for the unique EntrezGene ID for
each gene by The National Center for Biotechnology
Information (NCBI)'s EntrezGene system, which is
currently the only gene identification system supported
by FunNet to map genes to GO or KEGG biological
categories. The annotation of differentially expressed
genes was applied for two GO ontologies (cellular com-
ponent and biological process), and for the KEGG cat-
egories in this paper.
RESULTS
Syndrome characteristics of different groups
Compared with the PPFS group, the degree of PPF
was significantly lower in the QDS group. Compared
with the NC group, the degrees of Xue and Yang were
lower in both the PPFS and QDS group, but both did
not meet the standard of Xue deficiency and Yang defi-
ciency. However, the degree of Qi only in the QDS
group was significantly lower than that in the NC
group. These syndrome characteristics indicated that
the PPFS and QDS groups had single syndromes, with-
out secondary syndromes (Figure 1).
Gene expression patterns
In total, 6036 genes whose expressions in any group
were more than the average of all genes were involved
in the gene clustering. Many genes in the PPFS and
QDS groups either consistently or inconsistently ex-
pressed in significant differences when compared with
the NC group, according to the graded color (green
lines indicate down-regulated genes and red lines indi-
cate up-regulated genes). The consistent up- or
down-regulated genes perhaps reflect the characteristics
of liver cancer, and the genes with inconsistent varia-
tion in the two groups might be the characteristic
genes of specific syndromes (Figure 2).
Transcriptomic features of the pituitary
In the PPFS group, 548 up-regulated and 207
down-regulated genes were involved in the functional
analysis. Among these were 466 up-regulated and 160
down-regulated genes annotated with GO Biological
Process, 496 up-regulated and 160 down-regulated
genes annotated with GO Cellular Component, and
262 up-regulated and 48 down-regulated genes anno-
tated with categories of KEGG. In the QDS group,
536 up-regulated and 221 down-regulated genes were
involved in the functional analysis. Among these were
496 up-regulated and 168 down-regulated genes anno-
tated with GO Biological Process, 481 up-regulated
and 179 down-regulated genes annotated with GO
Cellular Component, and 230 up-regulated and 55
down-regulated genes annotated with categories of
KEGG.
Pituitary transcriptomic features related to liver
cancer and syndromes
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The relevant biological themes of pituitary differentially
expressed genes in the PPFS and QDS groups annotat-
ed by GO Biological Process, GO Cellular Compo-
nent, and KEGG are displayed in Figure 3A, B, and C
and Figure 4A, B, and C.
We found that both groups had many common anno-
tated themes. The up-regulated genes were annotated
mainly by functional themes related to metabolism, es-
pecially lipid metabolism. For example: oxidation-re-
duction, lipid metabolic process, metabolic pathways,
peroxisome proliferator-activated receptor (PPAR) sig-
naling pathway, and fatty acid metabolism, most of
these functions are always performed in the cytoplasm
(cytoplasm, mitochondrion, endoplasmic reticulum,
cytosol, and soluble fraction). Additionally, extracellu-
lar matrix (ECM) interactions were common [focal ad-
hesion and ECM-receptor interaction, which generally
happened in the extracellular space (extracellular space,
proteinaceous extracellular matrix) and plasma mem-
brane]. The down-regulated genes were mostly annotat-
ed by themes associated with the communication of
cells, especially nerve cells. For example: cell junctions,
synapses, cell projections, and the postsynaptic mem-
brane. Additionally, the themes related to the regula-
tion of genetic information processing were regulated
bidirectionally. For example, the negative/positive regu-
lation of transcription from RNA polymerase Ⅱ pro-
moter was up-regulated. However, transcription, regu-
lation of transcription, mRNA processing, RNA splic-
ing, and response to DNA damage stimuli were
down-regulated, all of which are usually processed in
the cytoplasm and nucleus.
Some distinctive categories were gathered in the PPFS
and QDS groups. The proportion of up-regulated
genes linking metabolism (insulin signaling pathway
and glycolipid, peroxisome, and pyruvate metabolisms)
in the PPFS group was higher than that in the QDS
group. However, the up-regulated genes related to can-
cer (angiogenesis, negative regulation of cell prolifera-
tion, cell proliferation, cell migration, and pathways in
cancer), and infection (phagosome, Staphylococcus au-
reus infection, antigen processing and presentation, au-
toimmune thyroid disease, and viral myocarditis) were
more in the QDS group. Moreover, the down-regulat-
ed genes associated with nerves (glutamatergic synapse
and neurotrophin signaling pathway), and the endo-
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Figure 1 Degrees of syndromes in the different groups
A: the degree of PPF was lower obviously in the QDS
group; B: the degree of Qi was significantly lower in the
QDS group; C: the degree of Xue was obviously lower
in both the PPFS and QDS group; D: there was no signif-
icance among the groups for degree of Yin; E: the de-
gree of Yang was obviously lower in both the PPFS and
QDS groups. PPF: poisonous pathogenic factors; NC:
normal control group; PPFS: poisonous pathogenic fac-
tors syndrome group; QDS: Qi deficiency syndrome
group. Significant differences compared with the PPFS
were designated as aP<0.05 and with the NC as bP<0.05.
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crine system (GnRH signaling pathway and gastric ac-
id secretion) were also more in the QDS group.
DISCUSSION
Liver cancer is considered a systemic disease, which re-
quires researchers to investigate the full pathological
changes in patients. Using the combined methods of
disease differentiation and syndrome differentiation in
the diagnosis and treatment of liver cancer, TCM has
utility in improving symptoms, reducing toxicity and
side effects of chemoradiotherapy, extending lifespan,
increasing quality of life, and preventing relapse and
metastasis of cancer.3
Syndrome differentiation is the method used in TCM
for disease diagnosis. For liver cancer patients, up to 30
syndromes were found in published papers reviewed by
Si et al,15 because no clinically consolidated standards
are used to categorize syndrome names. However, all
these syndromes can be divided into three categories:
excess syndromes, deficiency syndromes, and defi-
cient-excessive syndromes. In this study, two groups of
liver cancer mice with common syndromes were select-
ed: the PPFS group had excess syndrome (poisonous
pathogenic factors), and the QDS group had a mixture
of deficiency syndrome (Qi deficiency, which is the
most common deficiency syndrome in the liver cancer
patients15) and excessive syndrome (poisonous patho-
genic factors). The main aim of this study was to ex-
plore the material foundation of liver cancer with these
syndromes.
So far, TCM5 and Western Medicine6 hold that the
NEIN of cancer patients is disordered in addition to
the tissue with the solid tumor. One very important tis-
sue of NEIN, the pituitary, has a close relationship
with liver cancer and syndromes as Weisburger et al 16
and Liu et al 17 reported.
Liver is an important organ for maintaining the ho-
meostasis of lipid metabolism. Most research found
that the plasma lipid profiles were slightly decreased in
liver cancer.18 In the present study, we found that
many up-regulated genes in the pituitary in both
groups were enriched in the categories of metabolism,
particularly lipid metabolism. It is speculated that the
pituitary possibly increases its own lipid metabolism to
compensate for the lower level of plasma lipids during
liver cancer. The pituitary active extracellular matrix
(ECM) interaction is generally deemed to be connect-
ed to cancer progression.19 Additionally, liver cancer is
possibly metastatic to the pituitary, though the inci-
dence rate of this process was reported to be very low.20
Insufficient communication of nerve cells in the pitu-
itary likely poorly affect the ability of the neurohypoph-
ysis to store vasopressin and oxytocin from hypothala-
mus and its ability to release them into blood circula-
tion under the appropriate stimuli. The regulation of
genetic information processing is disordered because
all abnormal processes were accompanied with changes
in functional proteins translated from genetic informa-
tion.
We also observed the difference between the two
groups with different syndromes. Compared with the
QDS group, pituitary metabolism compensation abili-
ty was stronger in the PPFS group. There were two sig-
nificant differences in the QDS group from the PPFS
group. First, some cancer genes were up-regulated in
the QDS group, indicating that Qi deficiency probably
facilitates tumor metastasis from liver to pituitary,
which is consistent with previous reports.21 Second, a
number of infectious disease genes were affected, indi-
cating a reduction in the immune function of the pitu-
itary, possibly via nerve or endocrine. This effect is sim-
ilar to the standpoint that deficiency syndromes are
closely related to NEIN.5 Both of the two specialties of
the QDS group provide a theoretical foundation for
the treatment of liver cancer with Qi deficiency by
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Figure 2 Gene expression patterns of the PPFS and QDS
groups
A total of 6036 genes were involved in the gene clustering.
Green lines represent down-regulated genes and red lines
represent up-regulated genes. The lines of graded color
with pure green through black to pure red (excluding pure
green and pure red) indicate genes without differential ex-
pression compared with the normal control group. PPFS:
poisonous pathogenic factors syndrome group; QDS: Qi de-
ficiency syndrome group.
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strengthening the body resistance to eliminate patho-
genic factors.
Our findings of the transcriptomic features characteriz-
ing the pituitary role in liver cancer with different syn-
dromes confirm the strong relationship between the pi-
tuitary and liver cancer and syndromes. The interac-
tion and regulated mechanisms of these differentially
expressed genes remain to be further studied. In short,
our study reveals the relevance of the pituitary to dis-
ease and syndromes and opens new perspectives in un-
derstanding the role of the pituitary in the substantial
foundation of combined diseases and syndromes.
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